Body
Development of an international pharmaceutical innovation value chain for in silico drug discovery
Summary
- This project aims to develop novel inhibitors for specific targets, in collaboration with UK and French scientists, as well as members of the Drug Development Value-chain Consortium in Japan. We interact with X-ray crystallographers and computational chemists, by building comparative models and analysing docking and binding data. More information can be found here on the Biomedical Cluster Kansai website (in Japanese).
Funding
- International Collaboration programme, The Knowledge Cluster Initiative by the Ministry of Education, Culture, Sports, Science and Technology. (2007-2012) “Development of an international value chain for in-silico drug discovery” (Principal Investigator: Kenji Mizuguchi)
Collaborators:
- Hiroyoshi Matsumura and Tsuyoshi Inoue(Osaka University)
- Tom Blundell(University of Cambridge)
